3.66
price up icon11.93%   0.39
after-market Dopo l'orario di chiusura: 3.74 0.08 +2.19%
loading
Precedente Chiudi:
$3.27
Aprire:
$3.24
Volume 24 ore:
196.27K
Relative Volume:
2.45
Capitalizzazione di mercato:
$51.59M
Reddito:
$19.91M
Utile/perdita netta:
$-127.11M
Rapporto P/E:
-4.6959
EPS:
-0.7794
Flusso di cassa netto:
$-132.44M
1 W Prestazione:
+9.25%
1M Prestazione:
+14.02%
6M Prestazione:
-32.47%
1 anno Prestazione:
+0.33%
Intervallo 1D:
Value
$3.24
$3.7199
Intervallo di 1 settimana:
Value
$3.159
$3.7199
Portata 52W:
Value
$2.9178
$8.95

Affimed N V Stock (AFMD) Company Profile

Name
Nome
Affimed N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
78
Name
Cinguettio
@affimed
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
AFMD's Discussions on Twitter

Affimed N V Stock (AFMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-12 Iniziato H.C. Wainwright Buy
2022-10-10 Downgrade Stifel Buy → Hold
2022-08-18 Ripresa Wells Fargo Overweight
2022-03-31 Iniziato Piper Sandler Overweight
2022-02-23 Iniziato Cantor Fitzgerald Overweight
2021-10-21 Iniziato Truist Buy
2021-09-30 Iniziato Stifel Buy
2021-03-31 Iniziato Credit Suisse Outperform
2019-03-28 Iniziato SVB Leerink Outperform
2018-08-28 Aggiornamento Jefferies Hold → Buy
2017-07-14 Iniziato SunTrust Buy
2016-08-12 Downgrade Leerink Partners Outperform → Mkt Perform
2016-05-19 Downgrade Leerink Partners Outperform → Mkt Perform
2015-12-10 Iniziato Laidlaw Buy
2015-12-04 Iniziato Wells Fargo Outperform
2015-09-09 Iniziato Jefferies Hold
2015-08-06 Reiterato Oppenheimer Outperform
2015-06-22 Reiterato Jefferies Buy
Mostra tutto

Affimed N V Borsa (AFMD) Ultime notizie

pulisher
09:17 AM

Affimed Announces Acceptance of Three Abstracts at the 2024 - GlobeNewswire

09:17 AM
pulisher
09:00 AM

Affimed N.V. Announces Acceptance of Three Abstracts At the 2024 Ash Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma - Marketscreener.com

09:00 AM
pulisher
Oct 28, 2024

Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Affimed (NASDAQ:AFMD) Given Average Rating of “Buy” by Analysts - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Affimed (NASDAQ:AFMD) Short Interest Update - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

683 Capital Management, LLC Expands Stake in Affimed NV - Yahoo Finance

Oct 24, 2024
pulisher
Oct 15, 2024

Affimed Appoints New Director Amid Strategic Moves - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

Affimed N : Annual General Meeting Results Form 6 K - Marketscreener.com

Oct 15, 2024
pulisher
Oct 04, 2024

Affimed N : Presentation - Marketscreener.com

Oct 04, 2024
pulisher
Oct 03, 2024

Analysts Set Affimed (NASDAQ:AFMD) Target Price at $20.00 - MarketBeat

Oct 03, 2024
pulisher
Sep 30, 2024

Affimed Appoints New CEO, Shares Fall on Leadership Change - MSN

Sep 30, 2024
pulisher
Sep 21, 2024

Affimed appoints Shawn Leland as chief executive officer - MSN

Sep 21, 2024
pulisher
Sep 17, 2024

Affimed (NASDAQ:AFMD) Sees Significant Decrease in Short Interest - MarketBeat

Sep 17, 2024
pulisher
Sep 13, 2024

AFMDAffimed N.V. Latest Stock News & Market Updates - StockTitan

Sep 13, 2024
pulisher
Sep 12, 2024

Affimed N.V. Announces Upcoming EGM - TipRanks

Sep 12, 2024
pulisher
Sep 10, 2024

Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewswire

Sep 10, 2024
pulisher
Sep 10, 2024

Affimed (NASDAQ:AFMD) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Sep 10, 2024
pulisher
Sep 09, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD) - MarketBeat

Sep 09, 2024
pulisher
Sep 08, 2024

Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 08, 2024
pulisher
Sep 07, 2024

Affimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Call Transcript - Insider Monkey

Sep 07, 2024
pulisher
Sep 06, 2024

HC Wainwright Reaffirms Buy Rating for Affimed (NASDAQ:AFMD) - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Earnings call: Affimed reports promising clinical results and stable finances By Investing.com - Investing.com Australia

Sep 06, 2024
pulisher
Sep 06, 2024

Earnings call: Affimed reports promising clinical results and stable finances - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

Affimed NV (AFMD) Q2 2024 Earnings Call Transcript Highlights: F - GuruFocus.com

Sep 06, 2024
pulisher
Sep 06, 2024

Affimed N.V.: Q2 Earnings Snapshot - New Haven Register

Sep 06, 2024
pulisher
Sep 05, 2024

Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA) - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 05, 2024

Stifel holds Affimed at $5 target with new CEO at helm By Investing.com - Investing.com Canada

Sep 05, 2024
pulisher
Sep 05, 2024

Stifel holds Affimed at $5 target with new CEO at helm - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed Appoints Shawn M. Leland as Chief Executive Officer - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed Reports Second Quarter 2024 Financial Results & Business Update - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed NV reports results for the quarter ended in June 30Earnings Summary - xm.com

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed reports Q2 EPS (EUR1.01) vs. (EUR1.97) last year - TipRanks

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed N.V. Faces Substantial Mid-Year Losses - TipRanks

Sep 05, 2024
pulisher
Sep 05, 2024

Affimed N.V.: Q2 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria

Sep 05, 2024
pulisher
Sep 04, 2024

Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha

Sep 04, 2024
pulisher
Sep 04, 2024

Affimed NV (AFMD) Q2 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Sep 04, 2024
pulisher
Sep 03, 2024

Affimed names Shawn Leland as new CEO By Investing.com - Investing.com Canada

Sep 03, 2024
pulisher
Sep 03, 2024

Affimed appoints Shawn Leland as Chief Executive Officer - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

Affimed Appoints New CEO to Bolster Growth - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

Affimed names Shawn Leland as new CEO - Investing.com

Sep 03, 2024
pulisher
Aug 30, 2024

Affimed (AFMD) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Aug 30, 2024
pulisher
Aug 29, 2024

Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 - GlobeNewswire

Aug 29, 2024
pulisher
Aug 24, 2024

Affimed (NASDAQ:AFMD) Stock Price Crosses Below 200 Day Moving Average of $5.35 - Defense World

Aug 24, 2024
pulisher
Aug 24, 2024

Affimed (NASDAQ:AFMD) Stock Crosses Below 200 Day Moving Average of $5.35 - MarketBeat

Aug 24, 2024

Affimed N V Azioni (AFMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):